Feinberg Peter 4
4 · Immuneering Corp · Filed Jan 14, 2026
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Purchase
Class A Common Stock
[F1]2026-01-12$4.35/sh+20,000$86,904→ 135,441 total(indirect: By LLC)
Holdings
- 156,766
Class A Common Stock
- 392,242(indirect: General Partner of PF Associates L.P.)
Class A Common Stock
- 476,615(indirect: By LLC)
Class A Common Stock
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.315 to $4.38. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg|2026-01-14